Model-guided dose optimization of cefoperazone-sulbactam and levofloxacin for pneumonia and urinary tract infections in patients with hepatic dysfunction
American Journal of Translational Research · 2026 · 18 (2) · 1647-1662
DOI: 10.62347/gigu1376 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Translational Research, 2026. Verfasst von Hui Zhu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Hanchuan People's Hospital Hanchuan City, Xiaogan 431600, Hubei, China. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hanchuan People's Hospital Hanchuan City, Xiaogan 431600, Hubei, China.
- General Practice Department, The First People's Hospital of Chun'an County Hangzhou 311700, Zhejiang, China.
Zitieren
APA
Zhu, H., & Wang, Z. (2026). Model-guided dose optimization of cefoperazone-sulbactam and levofloxacin for pneumonia and urinary tract infections in patients with hepatic dysfunction. American Journal of Translational Research, 18(2), 1647-1662. https://doi.org/10.62347/gigu1376
Vancouver
Zhu H, Wang Z. Model-guided dose optimization of cefoperazone-sulbactam and levofloxacin for pneumonia and urinary tract infections in patients with hepatic dysfunction. American Journal of Translational Research. 2026;18(2):1647-1662. doi:10.62347/gigu1376
BibTeX
@article{Zhu2026,
author = {Zhu, Hui and Wang, Zhirou},
title = {Model-guided dose optimization of cefoperazone-sulbactam and levofloxacin for pneumonia and urinary tract infections in patients with hepatic dysfunction},
journal = {American Journal of Translational Research},
year = {2026},
volume = {18},
number = {2},
pages = {1647--1662},
doi = {10.62347/gigu1376}
}
EUVIMED